A Phase II Trial of CPT-11 in Recurrent Squamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study
- 30 September 1998
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 70 (3) , 334-338
- https://doi.org/10.1006/gyno.1998.5129
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- 54 Phase I study of irinotecan (CPT-11) and cisplatin by (CDDP) divided administration in patients with non-small cell lung cancer (NSCLC)Lung Cancer, 1997
- Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.Journal of Clinical Oncology, 1997
- Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1997
- Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.Journal of Clinical Oncology, 1996
- Irinotecan (CPT-11) and Characteristic Mucosal Changes in the Mouse Ileum and CecumJNCI Journal of the National Cancer Institute, 1995
- Phase I and pharmacokinetic trial of weekly CPT-11.Journal of Clinical Oncology, 1993
- Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: A Gynecologic Oncology Group studyAmerican Journal of Obstetrics and Gynecology, 1993
- Enhanced Antitumor Efficacy of a Combination of CPT‐11, a New Derivative of Camptothecin, and Cisplatin against Human Lung Tumor XenograftsJapanese Journal of Cancer Research, 1993
- Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1985